Search Results

Filter
  • 1-10 of  128,466 results for ""COVID-19 Vaccines""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Predictors of COVID-19 vaccine uptake: an online three-wave survey study of US adults.

  • Authors : Thorpe A; Department of Population Health Sciences, Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, USA. .; Department of Applied Health Research, University College London, London, UK. .

Subjects: COVID-19 Vaccines* ; COVID-19*; Adult

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Mar 12; Vol. 24 (1), pp. 304. Date of Electronic Publication: 2024 Mar 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

×
Academic Journal

Mortality risk after COVID-19 vaccination: A self-controlled case series study.

  • Authors : Xu S; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, United States. Electronic address: .

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: Vaccine [Vaccine] 2024 Mar 07; Vol. 42 (7), pp. 1731-1737. Date of Electronic Publication: 2024 Feb 22.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.

  • Authors : Zedan HT; Infectious Diseases Department, Biomedical Research Center, Research Complex, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans SARS-CoV-2 variants

  • Source: Journal of medical virology [J Med Virol] 2024 Mar; Vol. 96 (3), pp. e29527.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

×
Editorial & Opinion

Safety of a mRNA COVID-19 Vaccine in Patients with Indolent Systemic Mastocytosis.

  • Authors : Gouveia J; Serviço de Imunoalergologia. Centro Hospitalar Universitário de Santo António. Porto. Portugal.; Rodrigues MA

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; Mastocytosis, Systemic*/Mastocytosis, Systemic*/Mastocytosis, Systemic*/complications

  • Source: Acta medica portuguesa [Acta Med Port] 2024 Mar 01; Vol. 37 (3), pp. 224-225. Date of Electronic Publication: 2024 Mar 01.Publisher: Centro Editor Livreiro da Ordem dos Médicos Country of Publication: Portugal NLM ID: 7906803 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Adverse events following immunization reported with COVID-19 vaccines in Burkina Faso: Analysis of spontaneous reports

  • Authors : Sawadogo R; Institut supérieur des sciences de la santé (IN.S.SA), Université Nazi BONI (UNB), Bobo-Dioulasso, Burkina Faso; Agence nationale de régulation pharmaceutique (ANRP), ministère de la Santé, Ouagadougou, Burkina Faso.

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: Sante publique (Vandoeuvre-les-Nancy, France) [Sante Publique] 2024 Feb 23; Vol. 35 (6), pp. 149-159.Publisher: SFSP ; Rennes : ENSP Country of Publication: France NLM ID: 9216153 Publication Model: Print Cited Medium: Print ISSN: 0995-3914

Record details

×
Academic Journal

SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.

  • Authors : Hsieh M-S; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.; Hsu C-W

Subjects: Bacterial Proteins*/Bacterial Proteins*/Bacterial Proteins*/chemistry ; Bacterial Proteins*/Bacterial Proteins*/Bacterial Proteins*/genetics ; Bacterial Proteins*/Bacterial Proteins*/Bacterial Proteins*/immunology SARS-CoV-2 variants

  • Source: Journal of virology [J Virol] 2024 Feb 20; Vol. 98 (2), pp. e0154623. Date of Electronic Publication: 2024 Feb 01.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: JAMA [JAMA] 2024 Feb 20; Vol. 331 (7), pp. 554.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.

  • Authors : Norman M; Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Neonatal Medicine, Karolinska University Hospital, Stockholm, Sweden.

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: JAMA [JAMA] 2024 Feb 06; Vol. 331 (5), pp. 396-407.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Social network risk factors and COVID-19 vaccination: A cross-sectional survey study.

  • Authors : Memedovich A; Department of Community Health Sciences, Cumming School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, AB, Canada.; Orr T

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Vaccine [Vaccine] 2024 Feb 06; Vol. 42 (4), pp. 891-911. Date of Electronic Publication: 2024 Jan 18.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.

  • Authors : McMahan K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Wegmann F

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/virology SARS-CoV-2 variants

  • Source: Nature [Nature] 2024 Feb; Vol. 626 (7998), pp. 385-391. Date of Electronic Publication: 2023 Dec 14.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  128,466 results for ""COVID-19 Vaccines""